BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 25097095)

  • 1. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
    Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
    Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.
    Higano CS
    Urology; 2003 Feb; 61(2 Suppl 1):32-8. PubMed ID: 12667885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deprivation therapy: evidence-based management of side effects.
    Ahmadi H; Daneshmand S
    BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.
    Shahani S; Braga-Basaria M; Basaria S
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2042-9. PubMed ID: 18349064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement.
    Trost LW; Serefoglu E; Gokce A; Linder BJ; Sartor AO; Hellstrom WJ
    J Sex Med; 2013 Feb; 10 Suppl 1():84-101. PubMed ID: 23387914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of androgen-deprivation therapy for prostate cancer.
    Holzbeierlein JM; Castle EP; Thrasher JB
    Clin Prostate Cancer; 2003 Dec; 2(3):147-52. PubMed ID: 15040857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management.
    Kim HS; Freedland SJ
    Curr Opin Support Palliat Care; 2010 Sep; 4(3):147-52. PubMed ID: 20592607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of complications of androgen deprivation therapy in the older man.
    Mohile SG; Mustian K; Bylow K; Hall W; Dale W
    Crit Rev Oncol Hematol; 2009 Jun; 70(3):235-55. PubMed ID: 18952456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
    Owen PJ; Daly RM; Livingston PM; Fraser SF
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation therapy-associated vasomotor symptoms.
    Jones JM; Kohli M; Loprinzi CL
    Asian J Androl; 2012 Mar; 14(2):193-7. PubMed ID: 22286861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer.
    Taylor LG; Canfield SE; Du XL
    Cancer; 2009 Jun; 115(11):2388-99. PubMed ID: 19399748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer.
    Freedland SJ; Eastham J; Shore N
    Prostate Cancer Prostatic Dis; 2009; 12(4):333-8. PubMed ID: 19901933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
    Grossmann M; Zajac JD
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):289-93. PubMed ID: 21092052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of androgen deprivation therapy in men with prostate cancer.
    Chen AC; Petrylak DP
    Curr Oncol Rep; 2004 May; 6(3):209-15. PubMed ID: 15066232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of androgen-deprivation therapy in men with prostate cancer.
    Chen AC; Petrylak DP
    Curr Urol Rep; 2005 May; 6(3):210-6. PubMed ID: 15869725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms.
    Grunfeld EA; Halliday A; Martin P; Drudge-Coates L
    Cancer Nurs; 2012; 35(1):63-9. PubMed ID: 21558849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.
    Basaria S
    J Androl; 2008; 29(5):534-9. PubMed ID: 18567642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation therapy complications.
    Allan CA; Collins VR; Frydenberg M; McLachlan RI; Matthiesson KL
    Endocr Relat Cancer; 2014 Aug; 21(4):T119-29. PubMed ID: 24872511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
    Gardner JR; Livingston PM; Fraser SF
    J Clin Oncol; 2014 Feb; 32(4):335-46. PubMed ID: 24344218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation therapy for prostate cancer.
    Sharifi N; Gulley JL; Dahut WL
    JAMA; 2005 Jul; 294(2):238-44. PubMed ID: 16014598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.